Cargando…
Diagnostic ‘omics’ for active tuberculosis
The decision to treat active tuberculosis (TB) is dependent on microbiological tests for the organism or evidence of disease compatible with TB in people with a high demographic risk of exposure. The tuberculin skin test and peripheral blood interferon-γ release assays do not distinguish active TB f...
Autores principales: | Haas, Carolin T., Roe, Jennifer K., Pollara, Gabriele, Mehta, Meera, Noursadeghi, Mahdad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804573/ https://www.ncbi.nlm.nih.gov/pubmed/27005907 http://dx.doi.org/10.1186/s12916-016-0583-9 |
Ejemplares similares
-
In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis
por: Bell, Lucy C. K., et al.
Publicado: (2016) -
Persistent T Cell Repertoire Perturbation and T Cell Activation in HIV After Long Term Treatment
por: Turner, Carolin T., et al.
Publicado: (2021) -
Does tuberculosis threaten our ageing populations?
por: Byng-Maddick, Rachel, et al.
Publicado: (2016) -
Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study
por: Turner, Carolin T, et al.
Publicado: (2020) -
New Insights into the Limitations of Host Transcriptional Biomarkers of Tuberculosis
por: Noursadeghi, Mahdad, et al.
Publicado: (2021)